PI3K/AKT signalling has been shown to be involved in a broad range of processes within skeletal cell types (Figure 2) and exhibits dysregulation in both in vivo and in vitro models of muscular dystrophy. This evidence concerns the gene AKT1 and muscular dystrophy.